« Back to Record
Citation APA

Van Damme, K. K., Hoste, L., Declercq, J., De Leeuw, E., Maes, B., Martens, L., Colman, R., Browaeys, R., Bosteels, C., Verwaerde, S., Vermeulen, N., Lameire, S., Debeuf, N., Deckers, J., Stordeur, P., Depuydt, P., Van Braeckel, E., Vandekerckhove, L., Guilliams, M., Schetters, S., Haerynck, F., Tavernier, S. S., & Lambrecht, B. (2023). A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19. Science Translational Medicine, 15(710), eadi0252. doi:10.1126/scitranslmed.adi0252


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/370706

Van Damme, K. K., Hoste, L., Declercq, J., De Leeuw, E., Maes, B., Martens, L., Colman, R., Browaeys, R., Bosteels, C., Verwaerde, S., Vermeulen, N., Lameire, S., Debeuf, N., Deckers, J., Stordeur, P., Depuydt, P., Van Braeckel, E., Vandekerckhove, L., Guilliams, M., Schetters, S., Haerynck, F., Tavernier, S. S., & Lambrecht, B. (2023). A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19. Science Translational Medicine, 15(710), eadi0252. doi:10.1126/scitranslmed.adi0252